Recent Finacing
Recent Raise
Red Queen Therapeutics is a Cambridge-based clinical-stage biotech developing stapled lipopeptide fusion-inhibitor antivirals for coronaviruses, influenza, and other enveloped viruses, formulated for nasal, inhaled, or systemic delivery.
